Stocks and Investing Stocks and Investing
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023
Mon, December 18, 2023

Douglas Tsao Reiterated (VRDN) at Strong Buy and Held Target at $37 on, Dec 18th, 2023


Published on 2024-10-28 08:03:02 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $37 on, Dec 18th, 2023.

Douglas has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Douglas


  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $37 on, Monday, December 4th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 14th, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Monday, October 30th, 2023
  • Alex Thompson of "Stifel" Reiterated at Strong Buy and Held Target at $40 on, Wednesday, September 13th, 2023